Breast Cancer Testing is Changing

Rapid advances in precision oncology and new treatment for breast cancer are challenging pathologists to keep up. Protean BioDiagnostics provides a complete solution to assist community based pathologists provide the new testing their patients and oncologists need.

OUR SOLUTION

Protean BioDiagnostics has developed Protean MAPS™ for Breast.

Protean MAPS™ for Breast cancer is a comprehensive testing system that evaluates estrogen receptor, progesterone receptor, HER2, Ki67 and PDL1 when indicated in breast cancer specimens. In addition Protean BioDiagnostics will also provide access to molecular analysis, including PI3KCA, MSI, and multi-gene tumor NGS mutation analysis.

Protean BioDiagnostics views quality as its top priority and holds full CAP CLIA licensure, using only the best in class testing assays and products.